Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429

Long noncoding rnas (lncrnas) have been reported to play pivotal roles in a variety of cancers. however, lncrnas involved in hepatocellular carcinoma (hcc) initiation and progression remain largely unclear. in this study, we identified an lncrna gradually increased during hepatocarcinogenesis (lncrna-gihcg) using publicly available microarray data. our results further revealed that gihcg is upregulated in hcc tissues in comparison with adjacent non-tumor tissues. high gihcg expression is correlated with large tumor size, microvascular invasion, advanced bclc stage, and poor survival of hcc patients. functional experiments showed that gihcg promotes hcc cells proliferation, migration, and invasion in vitro, and promotes xenografts growth and metastasis in vivo. mechanistically, we demonstrated that gihcg physically associates with ezh2 and the promoter of mir-200b/a/429, recruits ezh2 and dnmt1 to the mir-200b/a/429 promoter regions, upregulates histone h3k27 trimethylation and dna methylation levels on the mir-200b/a/429 promoter, and dramatically silences mir-200b/a/429 expression. furthermore, the biological functions of gihcg on hcc are dependent on the silencing of mir-200b/a/429. collectively, our results demonstrated the roles and functional mechanisms of gihcg in hcc, and indicated gihcg act as a prognostic biomarker and potential therapeutic target for hcc.